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Telomerase is a ribonucleoprotein enzyme that adds telomeric DNA repeat sequences to 
the ends of linear chromosomes. The enzyme plays pivotal roles in cellular senescence 
and aging, and because it provides a telomere maintenance mechanism for ~90% of 
human cancers, it is a promising target for cancer therapy. Despite its importance, a high-
resolution structure of the telomerase enzyme has been elusive, although a crystal 
structure of an N-terminal domain (TEN) of the telomerase reverse transcriptase subunit 
(TERT) from Tetrahymena has been reported. In this study, we used a comparative 
strategy, in which sequence-based machine learning approaches were integrated with 
computational structural modeling, to explore the potential conservation of structural and 
functional features of TERT in phylogenetically diverse species. We generated structural 
models of the N-terminal domains from human and yeast TERT using a combination of 
threading and homology modeling with the Tetrahymena TEN structure as a template. 
Comparative analysis of predicted and experimentally verified DNA and RNA binding 
residues, in the context of these structures, revealed significant similarities in nucleic acid 
binding surfaces of Tetrahymena and human TEN domains. In addition, the combined 
evidence from machine learning and structural modeling identified several specific amino 
acids that are likely to play a role in binding DNA or RNA, but for which no 
experimental evidence is currently available.   
 
1. Introduction 
In most eukaryotes, a remarkable ribonucleoprotein enzyme, telomerase, is 
responsible for the synthesis and maintenance of telomeres, the ends of linear 
chromosomes [1, 2, 3]. Many exciting discoveries have been made in telomerase 
biology since 1984, when the enzyme was first identified in the ciliate, 
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 Tetrahymena thermophila, by Greider and Blackburn [4]. Recently, pivotal roles 
for telomerase in signaling pathways that regulate cancer, stress response, 
apoptosis and aging have been demonstrated [5, 6, 7, 8].   
Two essential roles of telomeres are protecting or "capping" chromosome 
ends and facilitating their complete replication (reviewed in 1, 2, 3). Typically, 
telomeres consist of arrays of simple DNA sequence repeats, ranging from ~50 
copies of 5'-TTGGGG-3' in Tetrahymena, to ~1000 copies of 5'-TTAGGG-3' in 
humans and other vertebrates.  The sequence of telomeric repeats is specified by 
an RNA template (TER), which varies in length from ~160 nts in ciliates to 
~1500 nts in vertebrates, and is an essential component of the catalytically 
active form of telomerase [2, 5]. Human telomerase is composed of hTER and 
two bound proteins, the telomerase reverse transcriptase component (hTERT) 
and dyskerin [9]. The regulation of telomerase activity involves interactions 
with a variety of other cellular proteins, many of which are essential for 
telomere homeostasis [8, 10]. 
Telomerase is a promising target for cancer therapy because it is generally 
present in very low levels in normal somatic cells, but it is highly active in many 
human malignancies [11]. Telomerase targeting strategies have included short 
interfering RNA (siRNA) knockdown of endogenous hTER and a combination 
of siRNA and expression of mutant forms of the hTER RNA, which become 
incorporated into the enzyme and inhibit proliferation in variety of different 
human cancer cell lines [11]. 
Despite its obvious clinical importance, currently there are no 
experimentally determined structures for the telomerase ribonucleoprotein 
complex or for telomerase complexes bound to telomeric DNA substrates, 
presumably because these are multisubunit structures.  The telomerase reverse 
transcriptase component, TERT, is generally thought to consist of four 
functional domains (see Figure 1): the essential N-terminal (TEN) domain, an 
RNA-binding domain (TRBD), reverse transcriptase (RT), and a C-terminal 
extension (TEC). Recently, a crystal structure of the essential N-terminal 
domain of TERT from Tetrahymena has been reported [12] and appears to 
represent a novel protein fold. Several conserved sequence motifs have been 
identified within the TEN domain on the basis of multiple sequence alignments 
and mutagenesis experiments [13, 14]. In addition, experiments directed at 
mapping DNA and RNA binding sites within TERTs from several organisms 
have identified specific amino acids that appear to contact either the DNA 
template or the RNA component [reviewed in 3]. In human telomerase, the TEN 
domain binds both DNA, specifically interacting with telomeric DNA substrates, 
and RNA, apparently binding in a non-sequence specific manner [12]. 
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Figure 1. TERT domain architecture. A) The telomerase reverse transcriptase (TERT) comprises 4 
functional domains: essential N-terminal (TEN) domain, RNA-binding domain (TRBD), reverse 
transcriptase (RT), and C-terminal extension (TEC). B) Cartoon illustrating TERT domain 
organization, and the RNA template (TER). The TEN domain is Tetrahymena structure (PDB ID: 
2B2A), and RT domain is from HIV-RT (PDB ID: 3HVT). Figure modeled after Collins, 2006 [2]. 
 
Although vertebrate TEN domain sequences share a high degree of 
sequence similarity, the TEN domains from more diverse species share very 
little sequence similarity (<30% identity), suggesting that a homology modeling 
approach to predicting the structure of the human TEN domain would be 
difficult.  However, an alignment of the N-terminal sequences of TERTs from 
organisms ranging from human to T. thermophila to S. cerevisiae, revealed 
several highly conserved residues distributed throughout the N-terminal domain, 
suggesting that TEN domains from diverse organisms may share similar 
architectures [12]. Based on this suggestion, we set out to test the hypothesis 
that the N-terminal domains of TERTs in diverse organisms not only share a 
similar overall three-dimensional fold, but may also have phylogenetically 
conserved DNA and RNA binding surfaces. We used a strategy in which 
comparative protein structural modeling approaches were integrated with 
sequence-based machine learning approaches for predicting DNA or RNA 
binding residues.  
 
2. Datasets, Materials and Methods 
2.1 Datasets 
RNA-protein interface dataset 
 
A dataset of protein–RNA interfaces was extracted from structures of known 
protein–RNA complexes in the Protein Data Bank (PDB) [15] solved by X-ray 
crystallography. Proteins with >30% sequence identity or structures with 
TEN TRB RT TEC
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 resolution worse than 3.5 Å were removed using PISCES [16]. The resulting 
dataset, RB147 [36], contains 147 non-redundant polypeptide chains. RNA-
binding residues were identified according to a distance-based cutoff definition: 
an RNA-binding residue is an amino acid containing at least one atom within 5 
Å of any atom in the bound RNA. RB147 contains a total of 6157 RNA-binding 
residues and 26,167 non-binding residues. The RB147 dataset [36] is larger than 
the RB109 dataset used in our previous studies [17, 18]. 
DNA-protein interface dataset 
A dataset of protein-DNA interfaces was extracted from structures of known 
protein-DNA complexes in the PDB [15]. Proteins with >30% sequence identity 
or structures with resolution worse than 3.0 Å and R factor > 0.3 were removed 
using PISCES [16]. The resulting dataset, DB208, contains 208 polypeptide 
chains, each at least 40 amino acids in length. DNA-binding residues were 
identified according to a definition based on reduction in solvent accessible 
surface area (ASA): an amino acid is a DNA-binding residue if its ASA 
computed in the protein-DNA complex using NACCESS [19] is less than its 
ASA in the unbound protein by at least 1 Å2 [20]. DB208 contains a total of 
5,721 interface residues and 39,815 non-interface residues. The DB208 dataset 
is larger than the DB171 dataset used in our previous studies [21].  
2.2  Algorithms for predicting interfacial residues 
 
We used sequenced-based Naïve Bayes classifiers [22, 23] for predicting 
protein-RNA interfaces [17, 18] and protein-DNA interfaces [21].  Briefly, the 
input to the classifier is a contiguous window of 2n+1 amino acid residues 
consisting of the target residue and n sequence neighbors to the left and right of 
the target residue, obtained from the protein sequence using the “sliding 
window” approach. The output of the classifier is a probability that the target 
residue is an interface residue given the identity of the 2n+1 amino acids in the 
input to the classifier. With Naïve Bayes classifiers, it is possible to tradeoff the 
rate of true positive predictions against the rate of false positive predictions, by 
using a classification threshold, θ, on the output probability of the classifier. The 
target residue is predicted to be an interface residue if its probability returned by 
the classifier is greater than θ, and a non-interface residue otherwise. The length 
of the window was set to 21 in the experiments described here. 
We used the implementation of the Naive Bayes classifier available in WEKA, an 
open source machine learning package [23] for training classifiers used to predict 
interface residues in this study. The performance of the protein-RNA interface predictor 
trained on RB147 dataset (RNABindR, http://bindr.gdcb.iastate.edu/RNABindR/), 
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 and estimated using leave-one-out sequence-based cross-validation, is documented 
in [36]. The performance of protein-DNA interface predictor trained on the 
DB208 dataset (DNABindR, http://cild.iastate.edu/DNABindR) and estimated 
using 10-fold sequence-based cross-validation, is comparable to that of the 
previously published protein-DNA interface predictor, which was trained on the 
DB171 dataset [21]. The RNA interface predictions on TEN domains were 
obtained by using Naïve Bayes classifiers trained on the RB147 dataset (high 
specificity setting of RNAbindR). The DNA interface predictions were obtained 
by DNABindR (θ=0.168) trained on the DB208 dataset. 
 
2.3 Structural modeling of telomerase TEN domains in human and yeast 
 
The N-terminal domains from human telomerase (GENBANK NP_937986) and 
yeast telomerase (GENBANK NP_013422) sequences, were threaded onto the T. 
thermophila telomerase N-terminal domain (TEN)  structure (PDB: 2b2a chain 
A) using FUGUE [24]. The output alignments were used for generating 3D 
coordinates for the N-terminal domains of human and yeast telomerase by 
MODELLER [25]. Among 15 generated models, the highest ranking model was 
chosen and refined using SCWRL [26] to reposition side-chains. Energy 
minimization was performed by 400 steps of steepest descent using the 
GROMOS96 force field [27] with a 9Å non-bonded cutoff in the Deep 
View/Swiss PDB-viewer [28]. One human TEN model was based on the 
Tetrahymena TEN structure in the PDB: 2b2aA, N-terminal domain of tTERT. 
For a second model, several templates were selected using PSI-BLAST [29] and 
the Swiss-Model HMM template library [30] to detect remote homologs of 
hTERT. The chosen templates were portions of the following PDB structures: 
1imhC, Tonicity-responsive enhancer binding protein (TONEBP)-DNA 
complex; 1jfiB, Negative Cofactor 2-TATA box binding protein-DNA complex 
(NC2-TBP-DNA); 2dyrM, bovine heart cytochrome C oxidase; 1b1uA, 
bifunctional inhibitor of Trypsin and Alpha-amylase from Ragi seeds; 2b2aA, 
N-terminal domain of tTERT. The templates were aligned and models were 
generated using the procedure described above. All generated structures were 
evaluated using the ANOLEA server [34]. 
 
2.4 Experimental identification of RNA and DNA binding residues 
 
Experimentally determined DNA and RNA binding sites in hTERT and tTERT 
were collected by mining relevant literature. Point mutations that affect RNA 
binding have not been reported, but Moriarty et al. showed that deletions at 
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 positions 30-39 and 110-119 in hTERT result in reduced RNA and DNA 
association, respectively [31, 32]. Conserved primer grip regions have been 
mapped in the TEN and RT domains of hTERT, between amino acids 137-141 
and 930-934 [33]. Alanine substitutions in the C-terminal region of TEN at 
positions Q168, F178, and W187 have been shown to substantially decrease 
tTERT association with DNA [12]. 
 
3. Results 
3.1 Rationale  
Computational and bioinformatic analyses can provide valuable insight into 
protein sequence-structure-function relationships, especially when the structure 
of a protein or complex is difficult to solve using experimental approaches. 
Surprisingly, despite the fascinating structural and regulatory complexity of 
telomerase, its pivotal role in cellular signal pathways, and its critical 
interactions with DNA, RNA and protein partners, very few studies have 
exploited bioinformatic or computational structural biology approaches to 
investigate the structure and function of telomerase. In this work, we use a 
combination of comparative structural modeling and sequence-based machine 
learning methods to test the hypothesis that the N-terminal domains of TERTs in 
diverse organisms share a similar overall architecture and conserved DNA and 
RNA binding surfaces. 
3.2 Sequence-based prediction of RNA and DNA binding sites in human 
and Tetrahymena TERT  
Conserved domains within the telomerase reverse transcriptase protein of 
human (hTERT) and Tetrahymena (tTERT) are illustrated in Figure 2. In 
previous work, we used a sequence-based machine learning approach to predict 
RNA binding residues in TERT sequences and showed that our predictions 
compared favorably with available experimental data [18]. Results of these 
previously published predictions are included in Figure 2 for comparison with 
DNA binding residues predicted in the current study (see Materials and 
Methods).  The predicted DNA and RNA binding regions in hTERT and tTERT 
are indicated by boxes under the middle sections of Figures 2A and B, 
respectively.  The lower portion of each figure shows specific examples, with 
boxed amino acids representing short deletions (in hTERT) or alanine-
substitution mutations (in tTERT), that have been shown to compromise or 
abolish DNA binding. Note that for hTERT, the predictions either overlap or 
surround the amino acids implicated by deletion (Figure 2A).  For tTERT, two 
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 of three experimentally-identified DNA binding residues lie within the predicted 
DNA binding region (Figure 2B). 
 
 
 
 
Figure 2. Predicted interface residues and conserved domains for telomerase reverse 
transcriptase (TERT). Mapped functional domains and conserved motifs of TERT are shown 
above shaded boxes representing clusters of predicted RNA and DNA interface residues. Predicted 
interface residues are indicated by a + below the amino acid sequence. A) Human telomerase reverse 
transcriptase (hTERT).  In the sequence shown, boxed amino acids 110-119 and 137-141, 
correspond to the template anchor site and a putative primer grip, implicated in forming the hTERT-
DNA active complex [31, 32, 34]. B) Tetrahymena telomerase reverse transcriptase (tTERT). The 
amino acid sequence shown represents the C-terminal end of the TEN domain.  Alanine mutations at 
positions Q168, F178 and W187 have been shown to significantly reduce hTERT-DNA association. 
Predicted interactions spanning amino acids 181-190 are located in a highly flexible, disordered 
region [12]. 
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i.                                          ii.                                      iii.                                    iv. 
 
 
 
 
B. 
                                     • 
T. thermophila      ----MQKINNINNNKQMLTRKEDLLTVLKQISALKYVSN--LYEFLLATEKIVQTSELDT 
H. sapiens          ----MPRAPRCRAVRSLLRSHYREVLPLATFVRRLGPQG---WRLVQRGDPAAFRALVAQ 
S. cerevisiae       --------------MKILFEFIQDKLDIDLQTNSTYKEN------LKCGHFNGLDEILTT 
                                                                               • 
T. thermophila      QFQEFLTTTII--ASEQNLVENYKQKYN-----QPNFSQLTIKQVID------DSIILLG 
H. sapiens          CLVCVPWD-----ARPPPAAPSFRQVSC-----LKELVARVLQRLCE---RGAKNVLAFG 
S. cerevisiae       CFALPNSR-------KIALPCLPGDLSH-----KAVIDHCIIYLLTG---ELYNNVLTFG 
                                                                •       • 
T. thermophila      NKQNY--VQQIGTTTIGFYVEYENINLSRQTLYSSNFRNLLNIFGEEDFKYFLIDFLVFT 
H. sapiens          FALLDGARGGPPEAFTTSVRSYLPNTVTDALRGSGAWGLLLRRVGDDVLVHLLARCALFV 
S. cerevisiae       YKIAR------NEDVNNSLFCHSAN-VNVTLLKGAAWKMFHSLVGTYAFVDLLINYTVIQ 
                            •  •        
T. thermophila      KVEQNGYLQVAGVCLNQYFSVQVKQKKWYKNN---- 
H. sapiens          LVAPSCAYQVCGPPLYQLGAATQARPPPHASGPRRR 
S. cerevisiae       FNG-QFFTQIVGNRCNEPHLPPKWVQRSSSSSAT-- 
 
Figure 3. Comparison of TEN domain structures and sequences and in Tetrahymena, human 
and yeast, S. cerevisiae.  A) Comparison of Tetrahymena TEN domain structure determined by X-
ray crystallography with modeled structures of TEN domains from other species. i) T. thermophila, 
experimentally-determined structure, PDB ID: 2b2aA [12];  ii) human structural model, based on 
threading using the T. thermophila 2b2aA structure as template;  iii) human structural model, based 
on threading using a composite of several different structures as template; iv) yeast, S. cerevisiae, 
structural model, based on threading using the T. thermophila 2b2aA structure as template.  B) 
Multiple sequence alignment of telomerase TEN domains from T. thermophila, H. sapiens, and S. 
cerevisiae [12]. Amino acids conserved in all 3 species in the multiple sequence alignment are 
highlighted.    
3.3 Structural modeling of N-terminal domain of TERT from human and yeast 
Our initial attempts to generate structural models of the human and yeast TEN 
domains by submitting their sequences to several web-based homology 
modeling servers were unsuccessful, due to failure of the servers to identify 
appropriate homology modeling templates (the pairwise sequence identity 
between TEN domains of hTERT and tTERT is < 20%).  However, the results 
of multiple sequence alignment (Figure 3B) and predicted secondary structure 
tTEN 
(PDB 2b2aA) 
hTEN model ii 
 (based on tTEN 
template) 
hTEN model iii 
(based on composite   
template) 
sTEN model iv 
(based on tTEN 
template) 
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 similarities (data not shown), led us to try threading, using the FUGUE server 
(see Materials and Methods). The Tetrahymena TEN domain structure (PDB ID 
2b2aA) was identified as the highest scoring structural template for both the 
human and yeast TEN domain sequences (hTERT: certain, with 99% 
confidence; sTERT: likely, with 95% confidence). Based on the alignments 
generated by FUGUE, we generated all-atom models and performed energy 
minimization to generate the final models illustrated in Figure 3A (see Materials 
and Methods for details). Two different models for the human TEN domain, 
model ii, based on the Tetrahymena TEN template, and model iii, based on a 
composite template from several different structures, were very similar to one 
another as well as to model iv, for the yeast TEN domain, despite their highly 
divergent amino acid sequences. Table 1 shows the root mean square deviation 
(RMSD) values calculated for comparison of the Tetrahymena TEN domain 
structure (determined by X-ray crystallography [12]) with the hTEN and sTEN 
modeled structures, using TOPOFIT [35] for structural alignment. 
 
Table 1. RMSD computed from structural alignments of TEN domain structures: tTEN,  
Tetrahymena, PDB structure, 2b2aA (Fig.3A, structure i); hTEN, human, modeled structure (Fig. 3A, 
model ii); sTEN, yeast, modeled structure (Fig. 3A, model iv). Alignments were performed using 
TOPOFIT [35] 
3.4 Analysis of RNA and DNA binding surfaces in human and Tetrahymena 
TEN domains 
To compare RNA and DNA binding surfaces in human and Tetrahymena TEN 
domains, we examined both our predicted nucleic acid binding sites and 
available experimental data in the context of the experimentally determined 
structure of Tetrahymena TEN domain [12] and modeled structure of the human 
TEN domain (model ii, Figure 3A).  Examples of these analyses are illustrated 
in Figures 4 and 5.  The predicted RNA binding residues in hTEN overlap with 
several RNA binding sites implicated by deletion experiments (Figure 4A, 
compare left and right models). Furthermore, additional putative RNA binding 
residues on the "back" side of the hTEN model (Figure 4B, left, in oval) co-
localize with an experimentally defined RNA binding site mapped onto the  
tTEN crystal structure (Figure 4B, right, in oval). 
 
Aligned Structures RMSD (Å)
tTEN vs hTEN 1.11 
tTEN vs sTEN 1.41 
sTEN vs hTEN 1.39 
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Figure 4. Comparison of predicted and experimentally determined RNA binding surfaces in 
TEN domains.  A) Sequence-based RNA binding site predictions mapped onto the hTERT TEN 
domain model ii (left) overlap with experimentally determined RNA binding residues (right); Black 
residues are predicted (left) or actual (right) RNA binding residues.  B) Another patch of predicted 
RNA binding residues in the hTEN model (left, in oval) co-localizes with an experimentally verified 
RNA binding region in tTEN (right). Figures 4 and 5 were generated using PyMol 
(http://pymol.sourceforge.net/). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Comparison of predicted and experimentally determined DNA binding surfaces in 
TEN domains. A) Residues predicted to interact with DNA (black), mapped onto tTEN, PDB 
2b2aA. Predicted binding sites encompass residues shown in B) which illustrates the only 3 
experimentally defined DNA binding residues in tTEN (see Fig. 2B). Note that additional predicted 
DNA binding residues in A (in oval) are consistent with C), which shows experimentally validated 
DNA binding residues in the human protein mapped onto our modeled structure of hTEN.  
B. tTEN Experimental DNA 
binding 
 (mapped on crystal structure) 
C. hTEN Experimental DNA 
binding 
 (mapped on model, view 2) 
A. tTEN Predicted DNA binding 
(mapped on crystal structure) 
hTEN Experimental RNA binding 
(mapped on model, view 1) 
hTEN Predicted RNA binding 
(mapped on model, view 2) 
tTEN Experimental RNA binding 
(mapped on crystal structure) 
hTEN Predicted RNA binding 
(mapped on model, view 1) 
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 Only three DNA binding residues in the TEN domain of tTERT have been 
experimentally identified: Q168, F178, and W187 (Figure 5B). Several additional 
putative DNA binding residues are predicted by our machine learning classifiers 
(Figure 5A). Some of these predicted residues in tTEN (in oval) co-localize with 
experimentally defined DNA binding residues in the human protein, when viewed 
in the context of our modeled structure of the hTEN domain (Figure 5C).  
Taken together, these results support our hypothesis that TEN domains in 
diverse organisms have similar three dimensional structures and conserved nucleic 
acid binding surfaces. Further, they identify additional putative interface residues 
that could be targeted in experiment studies. 
4. Summary and Discussion 
Telomerase is one of several clinically important regulatory proteins for which it has 
been difficult to obtain high resolution structural information.  The recent experimental 
determination of the structure of the N-terminal domain of tTERT, the telomerase 
reverse transcriptase component from Tetrahymena, suggests that at least partial 
structural information for human telomerase may soon become available. It seems 
unlikely, however, that experimental elucidation of the structure of the multisubunit 
RNP complex corresponding to the catalytically active form of telomerase will occur 
in the near future.  Thus, the integrative strategy proposed here, in which structural 
information gleaned from comparative modeling is combined with machine learning 
predictions of functional residues, can be expected to provide valuable insights into the 
sequence and structural correlates of function for telomerase and other "recalcitrant" 
proteins. We are currently pursuing several avenues for improving the reliability of 
machine learning predictions, including the use of different sequence representations 
and additional sources of input information (e.g., structure and phylogenetic 
information, when available) and more sophisticated machine learning algorithms. We 
are also pursuing additional approaches for protein structure prediction, including ab 
initio and fold recognition methods capable of incorporating predicted protein-protein 
contacts as constraints.  Given the large number of proteins with which telomerase 
interacts and the essential roles of telomerase in cellular signaling, aging, cancer, and 
other human diseases, this should continue to be rich and challenging area of research. 
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